AZAli Zamani

Ali Zamani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ali Zamani has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A case report of renal cell carcinoma metastasis revealed through late‐onset thyroid nodules

    by Abolfazl Khalafi‐Nezhad, Ali Zamani, Mahya Amini, Shahrzad Negahban

    Background: Renal cell carcinoma (RCC) is one of the most common and prevalent cancers all around the world with a prevalence of 3%. Approximately twenty percent of patients present with metastasis at the time of diagnosis, while late metastasis in renal cell carcinoma is a quite familiar phenomenon. Head and neck and particularly thyroid metastasis from RCC are rare events.Case: We present a case of a 75‐year‐old woman who developed thyroid nodules 13 years after nephrectomy for RCC. Diagnosis confirmed metastatic RCC through clinical history, histomorphology, and immunohistochemistry. Imaging studies revealed thyroid lesions without metastasis in other organs. The patient underwent total thyroidectomy and remains symptom‐free after 2 years of follow‐up.Conclusion: This case highlights the importance of considering metastatic lesions is crucial in managing thyroid nodules in patients with a history of cancer, particularly RCC.


  • Open Access

    Thyroid diseases in children and adults with celiac disease: A cross-sectional study

    by Ramin Niknam, Heydar Baseri, Laleh Mahmoudi, Mohammad Reza Fattahi, Ebrahim Fallahzadeh, Ali Zamani

    Background: There are few reports evaluating different factors, including the severity of duodenal histopathological findings and serological levels of celiac disease (CD), in increasing the probability of thyroid diseases (TD) in adults and children with CD, so, we designed this research. Methods: CD was defined as Marsh type 2 or higher in duodenal histopathology and serological levels of anti-transglutaminase antibodies (anti-tTG) equal to or greater than 18 IU/ml. To assess the likelihood of TD in CD patients, logistic regression analysis was employed. Results: 538 patients were included in this study. Of these, 354 (65.8%) were females and 184 (34.2%) were males. 370 (68.8%) patients were children. Overall, 57 (10.6%) patients had TD, of which 49 (9.1%) had hypothyroidism and 8 (1.5%) had hyperthyroidism. Adults had a significantly higher probability of developing TD than children (OR 1.9; 95% CI 1.1-3.4; P = 0.03). The odds of developing TD were also significantly higher in patients with family marriage in parents (OR 2.3; 95% CI 1.14.7; P = 0.03). Other variables such as gastrointestinal symptoms, anti-tTG levels, and severity of Marsh classification did not exhibit a substantial rise in the likelihood of TD development. Conclusion: The study findings indicated that the likelihood of developing TD in CD patients can be linked to advancing age and having family marriage in parents, while there was no significant association observed with anti-tTG levels, severity of histological damage, and gastrointestinal symptoms.


  • Safflower (Carthamus tinctorius L.) oil could improve abdominal obesity, blood pressure, and insulin resistance in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled clinical trial

    by Maede Ruyvaran, Ali Zamani, Alireza Mohamadian, Mohammad M. Zarshenas, Mohammad Hassan Eftekhari, Saeedeh Pourahmad, Ebrahim Fallahzadeh Abarghooei, Abolfazl Akbari, Majid Nimrouzi


  • Open Access

    Effect of protein and carbohydrate distribution among meals on quality of life, sleep quality, inflammation, and oxidative stress in patients with type 2 diabetes: A single‐blinded randomized controlled trial

    by Fatemeh Nouripour, Zohreh Mazloom, Mohammad Fararouei, Ali Zamani

    Background/Objectives Patients with diabetes mellitus have a lower quality of life and sleep compared with healthy individuals. Nutrition therapy has an important role in the management of diabetes and can improve inflammation and quality of life in patients with diabetes. The present study aimed to evaluate the effect of high-protein versus high-carbohydrate intake during evening meal on quality of life, sleep quality, inflammation, and oxidative stress in subjects with type 2 diabetes. Subjects/Methods This is a 10-week randomized controlled trial. 96 adult patients with type 2 diabetes were assigned into one of the following three groups: standard evening meal (ST), high-carbohydrate evening meal (HC), and high-protein evening meal (HP). The effect of these diets was examined on high-sensitivity C-reactive protein, malondialdehyde, quality of life, and sleep quality. Results Sleep quality improved significantly in all groups (p < .05). The quality of life and high-sensitivity C-reactive protein improved in all groups except for the HP group (p < .05). Serum malondialdehyde level did not change significantly throughout the study (p > .05). Conclusions Small manipulation of protein and carbohydrate distribution among the meals might not affect sleep quality. A diet with an even distribution of macronutrients among the meals or with a higher percentage of carbohydrates in the evenings can improve the quality of life and reduce inflammation in patients with type 2 diabetes, while a diet with a higher percentage of protein in the evenings may not improve it.


  • Protein and carbohydrate distribution among the meals: effect on metabolic parameters of patients with type 2 diabetes: a single-blinded randomised controlled trial

    by Fatemeh Nouripour, Zohreh Mazloom, Mohammad Fararouei, Ali Zamani

    Studies have revealed that the timing of macronutrient ingestion may influence body weight and glucose tolerance. We aimed to examine the effect of high protein v. high carbohydrate intake at the evening meal on metabolic parameters of patients with type 2 diabetes. This is a single-blinded, parallel, randomised controlled trial. Ninety-six patients with type 2 diabetes, aged 32–65 years with a mean BMI of 28·5 (sd 3·4) kg/m2, were randomly assigned into one of these three groups: standard evening meal (ST), high-carbohydrate evening meal (HC) and high-protein evening meal (HP). Then, the patients were followed for 10 weeks. HbA1c, fasting blood glucose, fasting insulin, insulin resistance, TAG, LDL-cholesterol, VLDL-cholesterol, diastolic blood pressure, body weight, body fat percentage and waist circumference decreased significantly in all three groups (P < 0·05). HbA1c showed more improvement in the ST compared with the HP group (–0·45 (sd 0·36) v. –0·26 (sd 0·36)). Reductions in BMI and body weight were significantly higher in the ST compared with the HP group (P < 0·05). Reductions in total cholesterol, non-HDL-cholesterol and systolic blood pressure were significant in all groups, except for the HP group. Non-HDL-cholesterol:HDL-cholesterol remained unchanged in all groups. The results of the present study revealed that even distribution of carbohydrates and protein among meals compared with reducing carbohydrates and increasing protein at dinner may have a more beneficial effect on glycaemic control of patients with type 2 diabetes.


  • PREDICTING RETINOPATHY RISK AMONG DIABETIC PATIENTS: A DATA MINING APPROACH

    by Saghar Foshati, Malihe Sabeti, Ali Zamani

    In medicine, data collection plays an important role in the diagnosis of diseases and treatment of patients. Physicians have to cope with a large amount of patient-related data, and they often have to review the patient’s whole history or other similar cases. Data is mainly collected to find out if there are related patterns and results that can shed light on the nature of the investigated disease. Mechanized data mining has tremendous value in the diagnosis and treatment of diseases, and can be especially helpful in the diagnosis and treatment of diabetes, a disease that inflicts a large portion of the population. Now, diabetes is the fourth cause of mortality among the general population in developing countries. Retinopathy is a chronic complication of diabetes that has serious consequences including blindness if not diagnosed as early as possible. This study uses a sample of 310 Diabetic patients, half of them have the diagnosis of retinopathy (n=155) and investigates 29 variables including age, gender...


  • Open Access

    Effect of Low Glycemic Index Diet Versus Metformin on Metabolic Syndrome

    by Shirin Rajabi, Zohreh Mazloom, Ali Zamani, Hamid Reza Tabatabaee

    Background: Metabolic syndrome (MetS) continues to be highly prevalent and contributes to a rapidly growing problem worldwide. The most important therapeutic intervention for metabolic syndrome is diet modification, an intervention whose efficacy has been proven for metabolic syndrome. Objectives: The aim of the present study was to compare the effects of low glycemic index diet versus metformin on MetS components in adults with MetS. Patients and Methods: Fifty-one adults with MetS participated in this randomized controlled clinical trial. Patients were randomly allocated to two groups of metformin and low glycemic index diet. The intervention period was eight weeks. The studied participants were compared at baseline and the end of the trial, regarding the following factors: weight, blood pressure, waist circumference, fasting blood sugar, hemoglobin A1c and lipid profiles (Triglyceride (TG), Total Cholesterol (TC), Low-Density Lipoprotein (LDL) cholesterol, and High-Density Lipoprotein (HDL) cholesterol). Results: The anthropometric measurements, Fasting Blood Sugar (FBS), Hemoglobin A1c, serum lipid profiles (TG, TC, LDL-C, HDL-C) and lipoprotein ratio (LDL/HDL) showed a significant decrease after the intervention in both groups (P < 0.05). Comparison of the difference between the two groups was not significant, except for the mean reduction in FBS, which was more in the metformin group although this was not clinically significant. Conclusions: This study supports the assumption that low glycemic index diet as well as metformin can positively affect metabolic syndrome components. Keywords: Glycemic Index, Metabolic Syndrome X; Metformin


  • Open Access

    Diacylglycerol Kinase ζ (DGKζ) Is a Critical Regulator of Bone Homeostasis Via Modulation of c-Fos Levels in Osteoclasts

    by Ali Zamani, Corinne Decker, Viviana Cremasco, Lindsey Hughes, Deborah V Novack, Roberta Faccio

    Increased diacylglycerol (DAG) levels are observed in numerous pathologies, including conditions associated with bone loss. However, the effects of DAG accumulation on the skeleton have never been directly examined. Because DAG is strictly controlled by tissue‐specific diacylglycerol kinases (DGKs), we sought to examine the biological consequences of DAG accumulation on bone homeostasis by genetic deletion of DGKζ, a highly expressed DGK isoform in osteoclasts (OCs). Strikingly, DGKζ‐/‐ mice are osteoporotic because of a marked increase in OC numbers. In vitro, DGKζ‐/‐ bone marrow macrophages (BMMs) form more numerous, larger, and highly resorptive OCs. Surprisingly, although increased DAG levels do not alter receptor activator of NF‐κB (RANK)/RANK ligand (RANKL) osteoclastogenic pathway, DGKζ deficiency increases responsiveness to the proliferative and pro‐survival cytokine macrophage colony‐stimulating factor (M‐CSF). We find that M‐CSF is responsible for increased DGKζ‐/‐ OC differentiation by promoting higher expression of the transcription factor c‐Fos, and c‐Fos knockdown in DGKζ‐/‐ cultures dose‐dependently reduces OC differentiation. Using a c‐Fos luciferase reporter assay lacking the TRE responsive element, we also demonstrate that M‐CSF induces optimal c‐Fos expression through DAG production. Finally, to demonstrate the importance of the M‐CSF/DGKζ/DAG axis on regulation of c‐Fos during osteoclastogenesis, we turned to PLCγ2+/‐ BMMs, which have reduced DAG levels and form fewer OCs because of impaired expression of the master regulator of osteoclastogenesis NFATc1 and c‐Fos. Strikingly, genetic deletion of DGKζ in PLCγ2+/‐ mice rescues OC formation and normalizes c‐Fos levels without altering NFATc1 expression. To our knowledge, this is the first report implicating M‐CSF/DGKζ/DAG axis as a critical regulator of bone homeostasis via its actions on OC differentiation and c‐Fos expression. © 2015 American Society for Bone and Mineral Research.


  • Open Access

    Folic acid may be a potential addition to diabetic foot ulcer treatment - a hypothesis

    by Mansooreh Bagheri, Behnam Moein Jahromi, Ali Zamani

    Delayed wound healing in diabetes is a challenging medical and societal problem for which there is currently no efficacious treatment. One of the major contributors of this problem is nitric oxide (NO) deficiency. NO is a critical signalling molecule essential for normal wound repair. Sustained hyperglycaemia in diabetes leads to increased vascular superoxide production, which inactivates NO and causes vascular dysfunction. New therapeutic regiments and strategies to enhance endothelial NO production are a new hope to improve impaired diabetic wound healing. One of the agents that have the ability to improve endothelial NO generation in diabetic patients is folic acid. Folic acid ability to conserve NO bioactivity may be due to homocysteine-lowering effects of folates, antioxidant actions and effects on cofactor availability. Considering these data, we hypothesised that folic acid supplementation may ameliorate delayed diabetic wound healing by increasing NO bioavailability. The potential of exogenous folic acid as an inexpensive and safe oral therapy stimulates ongoing investigations.